The truth about Japan and Ivermectin

Note: This article was originally published on December 23, 2021 on Wordpress and received over 10,000 views. DuckDuckGo linked to it; Google censored it. Google also controls Wordpress’s ad revenue for which I had paid for the privilege to advertise on. Google censored the advertising revenue.

As Japan's COVID rates surged in the Summer of 2021, Dr. Haruo Ozaki of the Toyko MMA recommended to the public that they begin to use Ivermectin to stop the Pandemic. This announcement came after over a year's discussion of the need for clinical trials of Ivermectin in Japan. Ivermectin has a long history in Japan, where the properties of the bacterium is is based on were discovered by Satushi Omura of Kitasato University of Tokyo, Japan around the early 1970s. Kitasato University sent the bacterium Streptomyces avermectinius to Merck where they modified the active compounds into what became Ivermectin.

Kitasato University began discussions with Merck as early as May, 2020 to start clinical trials of Ivermectin for COVID-19. For whatever reason, (this topic needs more research), Japanese clinical trials didn't begin until much later and they didn't involve Merck. It is clear that during Japan's COVID surge in the Summer of 2021, that medical professionals were frustrated with the lack of adequate clinical trials of Ivermectin, but were so sure of its potential that they felt a public duty to speak on the likely candidate to stop COVID.

After the recommendation Dr. Haruo Ozaki in August 2021, there is some information that imports of Ivermectin into Japan increased in September, although it is unclear to what extent Japan increased its consumption of Ivermectin. There is not much information to go on. Two things are very clear, however. 1. COVID cases fell rapidly to very low levels. 2. COVID vaccinations fell rapidly to very low levels.

During the crash of the Pandemic and vaccines in Japan in the Fall of 2021, media in the United States began an aggressive disinformation campaign against any suggestion that both 1. Japan was using Ivermectin, and 2. Japan had switched from vaccines to Ivermectin.

They used official statements that Japan has not approved Ivermectin. While true, that doesn't mean people weren't using it. They didn't report on whether or not people were using it.

They said that Japan has not abandoned the vaccines for Ivermectin, again using official language. Anyone can look up the vaccination rates in Japan in "Our World in Data." Here, the US media's "fact check" agenda to lie to the public is blatant because vaccinations had obviously fallen from high to low levels by the dates that these media outlets were publishing their "fact checks." There was no excuse for them to miss it.

So while, officially, Japan has not discontinued the use of vaccines, people just aren't taking them. The type of headlines and selective information that these outlets use are obviously meant to create a false impression.

The following is my theory, which I also believe to be truth, proven beyond a reasonable doubt to myself. COVID case rates in Japan fell to both increased use of Ivermectin and decreased use of Vaccines. Vaccines are the main driver of COVID rates, albeit with some time lag in data. I reference Luc Montagnier in general on this theory. If enough vaccines are substituted for other treatments, the Pandemic crashes. Media is deliberately concealing this truth from the pubic.

The following is all reference material. I'd like to add more to it on the obstruction of clinical trials of Ivermectin in Japan at some point. So check back.

May 13, 2020. Trial Site News: Kitasato University in Discussions with Merck to Conduct Ivermectin Clinical Trial Targeting COVID-19. "A Kitasato University Professor named Satoshi Omura, a 2015 Nobel Prize winner, developed the original findings that was thereafter used to create the drug. Now Nikkei Asian Review reports that the Tokyo-based university (Kitasato University) will consider a clinical trial using the drug to target COVID-19."

May 7, 2021. Trial Site News. Morimasa Yagisawa, visiting professor at Kitasato University, Omura Satoshi Memorial Institute in Tokyo, went on the record that the World Health Organization, drug regulators, and health policy makers shouldn’t ignore anymore the growing data that ivermectin can be an effective and safe adjuvant treatment for COVID-19. Citing accumulating clinical trials data, including many doctor-initiated studies, the professor cited in a virtual interview that 105 studies of ivermectin associated with the coronavirus across 32 nations have been registered, of which 24 have been completed and published. The professor declared that “ivermectin is almighty for prophylaxis, for treatment of early and late stage, and also for long COVID-19 (or) post-acute sequelae (of SARS-CoV-2).” 

August 13, 2021. Japan. Haruo Ozaki, chairman of the Tokyo Metropolitan Medical Association, held an emergency press conference on the 13th, regarding the rapid increase in the number of people infected with the new coronavirus. ... The average number of newly infected people in Tokyo for 7 days was 3934 per day as of the 11th, which is about twice that of 2 weeks ago. ... "The situation is that the whole country is suffering... No one will listen to me, so I will come up with a new policy. “ "I want you to show a clear exit strategy."

"The antiparasitic drug "ivermectin" shows the number of infections and deaths of the new corona in a country that is prophylactically administered for another disease in Africa. It is necessary to thoroughly study the clinical trial, but it seems that we are at the stage where it is okay to have the patient give an informed outlet and get permission to use it. "

September 2021. Japan Times. Authorities in Japan note a large increase of Ivermectin imports into Japan. "Authorities have flagged concerns over scores of messages posted on websites for agents that import drugs into Japan from those who have mail ordered the anti-parasite drug ivermectin. “I just received the package and, to prevent (coronavirus) infection, I’m going to take it from today,” a 52-year-old man wrote in a message posted in September. ... The drug, used globally to treat parasitic worms and skin conditions, has not been officially approved for use to treat COVID-19 in Japan, the U.S. or most countries in Europe. The health ministry says the drug should be used only in clinical trials in Japan. ... But that has not dissuaded some unvaccinated people from seeking out the drug in case they are infected with the coronavirus... Amid a lack of convincing clinical data in Japan, Kitasato University Hospital worked on a doctor-led midstage clinical trial, the results of which are not yet available. Kowa Co. has recently launched a final-phase clinical trial. The Tokyo Medical Association has also extended its support to Kowa’s trial. At the height of Japan’s fifth wave in mid-August, its president, Haruo Ozaki, proposed the emergency use of ivermectin to deal effectively with the pandemic. “Although an examination is necessary by conducting a clinical trial properly, under a strained situation like this, I think we’ve reached a stage where it’s OK to have the authorization issued to use ivermectin on patients after getting their informed consent,” he told reporters on Aug. 13. To ascertain its efficacy, the U.K.’s Platform Randomized Trial of Treatments in the Community for Epidemic and Pandemic Illnesses, the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and other nonhospital settings, started investigating ivermectin’s use in adults 18 years old and above in June, but the trial is currently paused due to temporary supply issues.

October 29, 2021. AP News reports "Japan has not substituted ivermectin for COVID-19 vaccines." CLAIM: “Japan has pulled the vaccines and substituted ivermectin — and in one month, wiped COVID out in that country.” AP’S ASSESSMENT: False. Japan has not stopped the use of coronavirus vaccines, nor has it substituted them with the parasite drug ivermectin, according to a list of COVID-19 approved medical products from Japan’s Ministry of Health. Additionally, the pandemic has not ended in the country, though new COVID-19 cases have plummeted from a summer peak.

November 1, 2021: Reuters: "Fact Check-Japan has not abandoned its COVID-19 vaccine rollout in favour of ivermectin."

November 5, 2021: USA Today: "Fact check: Japan did not stop its COVID-19 vaccine rollout and switch to ivermectin to treat virus."

December 20, 2021. NPR writes: "The riddle of Japan's dramatic drop in COVID numbers." They quote Dr. Hideaki Oka: "We have had zero COVID patients in our hospital for two months straight," (Dr. Hideaki Oka) explains, "so we've been able to concentrate on general medicine just as in pre-COVID times." The turnaround has been so dramatic it has left experts and observers struggling to explain it. Cases dropped by more than 99% from their peak. Japan has seen less than one death a day in recent weeks, its lowest level since July 2020." Dr. Oka: "We think it is due to countermeasures taken by many citizens and institutions, and accelerated vaccination, thanks to medical staffs' efforts and citizens' understanding." NPR did not elaborate on the "countermeasures taken by many citizens."

There will be no Dark Winter in the land of the Rising Sun, President Biden.

END